Company Filing History:
Years Active: 2019-2024
Title: Prakash Manikwar: Innovator in Antibody Formulations
Introduction
Prakash Manikwar is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. With a total of 5 patents to his name, his work has the potential to impact various therapeutic areas, including asthma and cancer treatment.
Latest Patents
One of his latest patents is focused on dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereof. This technology relates to dry powder formulations of antibodies specific for TSLP, which can be used in methods of treating asthma through pulmonary delivery. Another significant patent involves bispecific binding proteins and their uses. This disclosure provides proteins that bind two epitopes and are bivalent for binding to each of the first and second epitopes. It also includes methods for inducing an immune response and treating or preventing cancer by administering these proteins and compositions.
Career Highlights
Prakash Manikwar has been associated with Medimmune Limited, where he has been instrumental in advancing research and development in antibody technologies. His innovative approaches have led to the creation of formulations that could enhance therapeutic efficacy.
Collaborations
He has collaborated with notable colleagues such as Srinath Kasturirangan and Changshou Gao, contributing to a dynamic research environment that fosters innovation.
Conclusion
Prakash Manikwar's work exemplifies the intersection of innovation and biotechnology, with his patents paving the way for new treatments in asthma and cancer. His contributions continue to influence the field and hold promise for future advancements.